Oncology tourism: what to know

Travelling for cancer treatment is not like travelling for cosmetic surgery. Cancer is treated in cycles, by multidisciplinary teams, with decisions reviewed every few weeks, so the key question is not "where is the best hospital" but "which part of my treatment makes sense abroad and how is it coordinated with my home team".

There are four legitimate reasons to seek care in another country. First, a second opinion on diagnosis or staging: it is cheap, fast and sometimes solved by sending the biopsy block and images without travelling. Second, access to techniques unavailable in your system, such as proton therapy (especially valuable in paediatric, skull-base and ocular tumours) or highly complex surgery. Third, waiting times. Fourth, clinical trials and advanced therapies (CAR-T, radioligands, combined immunotherapies) whose inclusion criteria match your case.

Reference destinations differ by profile. Germany leads in proton therapy (Essen, Heidelberg), precision oncology and hepatobiliary surgery. Israel combines strong university centres with international departments used to foreign patients. Singapore and South Korea lead in Asia for robotic surgery and stereotactic radiotherapy. Spain offers reference units at a cost well below the US and in your language. India delivers accredited quality at a fraction of the price, with distance as the trade-off.

What to prepare before moving: a full translated clinical report, pathology with immunohistochemistry and molecular profiling, images in DICOM format (not screenshots), the list of treatments already received with doses, and recent lab work. Always ask the new centre for a written plan stating cycles, expected duration, total estimated cost and what will be done on site versus what can continue at home.

Risks nobody should downplay: continuity gaps between cycles, toxicities appearing after you return (immunotherapy pneumonitis, febrile neutropenia, mucositis) that require an informed local team, travel insurance excluding pre-existing disease, fitness to fly after surgery or with anaemia, and expectations inflated by clinics selling unvalidated "cures". Any centre guaranteeing a cure or offering therapies without scientific publication should be ruled out immediately.

Costs vary hugely: a documentary second opinion runs €300-1,500; a full proton therapy course €40,000-90,000; major cancer surgery with admission €15,000-60,000 depending on the country. Ask for quotes with headroom for complications and an extended stay.

At medviajes we help compare accredited centres by volume and outcomes, transfer reports and imaging, and organise the stay, companion and follow-up coordinated with your oncologist. Therapeutic decisions must always be made with a qualified oncology team.